Find out why the pharmaceutical contract manufacturing market is heating up: M&A activity continues to rise. Get our new report: https://go.ey.com/2AIlfBr

1. The pharmaceutical contract
manufacturing market is heating up:
M&A activity continues to rise
EY CDMO Study
The pharmaceutical contract development and manufacturing
(CDMO) market is heating up: three recent multi-billion dollar
acquisitions of large players are just some examples for the rising
M&A activity. At a time when Big Pharma, biotech and CDMO
companies are reviewing their business models, the CDMO
market offers considerable opportunities for current players as
well as new entrants.
16.2
93
89
77
65
76
31%
63%
21%
28%
8.5
6%
2012
4.9
2013
51%
31%
2016
12%
33%
36%
67%
23%
2015
11.8
20%
2014
11%
10.9
65%
Number of CDMO transactions (global) North America
Europe
Asia-Pacific
Cumulative deal value
(sum of EVs, US$b)